Mean analyst price target for Aura Biosciences (AURA) implies a 201.5% upside. Analysts show strong agreement in raising earnings estimates, supporting potential upside despite the historical unreliability of mean price-target metrics. The view is positive but cautious and is likely to have limited market impact beyond AURA's shares.
Mean analyst price target for Aura Biosciences (AURA) implies a 201.5% upside. Analysts show strong agreement in raising earnings estimates, supporting potential upside despite the historical unreliability of mean price-target metrics. The view is positive but cautious and is likely to have limited market impact beyond AURA's shares.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
